Blood Pressure Pills Recalled Over Cancer Risk
Blood Pressure Pills Recalled Over Cancer Risk
Medications may contain high levels of a probable human carcinogen
Dhiraj Singh/Bloomberg via Getty Images Two types of blood pressure medications sold by Lupin Pharmaceuticals Inc. were voluntarily recalled by the manufacturer after routine ingredient testing detected high levels of N-nitrosoirbesartan, a potentially cancer-causing impurity. The company recalled all batches of its Irbesartan tablets (75 mg, 150 mg and 300 mg) and Irbesartan-Hydrochlorothiazide (150 mg/12.5 mg and 300 mg/12.5 mg). The recalled tablets were packaged in 30 - and 90 -count bottles and distributed nationwide to wholesalers, drug chains, mail order pharmacies and supermarkets. Recalled blood pressure medications
Medication Lot Number Irbesartan Tablets, 75mg H000843, H805727, H901579, H000844, H000964, H804311, H805267, H805268, H805269, H805725, H805726, H901497, H901577, H901578, H902258 Irbesartan Tablets, 150 mg H804403, H805251, H805640, H901580, H804492, H805252, H805253, H805641, H805642, H805643, H901581, H902139, H902140 Irbesartan Tablets, 300 mg H804310, H900050, H902262, H000845, H000846, H000965, H805345, H805346, H805347, H805724, H900061, H900062, H900445, H901489, H901490, H901491, H902261 Irbesartan-Hydrochlorothiazide Tablets, 150mg/12.5mg H804537, H805148, H900063, H900522, H901582, H000963, H804507, H804536, H805070, H805149, H900064, H900523, H901583, H902530 Irbesartan-Hydrochlorothiazide Tablets, 300mg/12.5mg H804192, H805348, H900065, H902264, H804082, H804121, H804338, H804538, H804539, H805349, H805350, H900066, H900067, H902265, H902275, H902276, H902531, H902532 Source: FDA Advice for consumers
Patients who are taking any of the recalled medications are advised to continue taking them and contact their pharmacist, physician or medical provider to discuss an alternative treatment option. Meanwhile, Lupin Pharmaceuticals is arranging the return of the recalled drugs with its distributors. Consumers with questions should contact Inmar Rx Solutions at 855-769-3988 or 855-769-3989 Monday through Friday from 9 a.m. to 5 p .m . ET. For reimbursement, make sure the lot number matches the batches recalled (found on the side of the bottle label). Any adverse reactions or quality problems experienced with the use of these products may be reported to the Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting program or by mail or fax using this . What is N-nitrosoirbesartan
N-nitrosoirbesartan is an impurity that is considered a “probable” human carcinogen, based on results from laboratory tests. Aaron Kassraie writes about issues important to military veterans and their families for AARP. He also serves as a general assignment reporter. Kassraie previously covered U.S. foreign policy as a correspondent for the Kuwait News Agency’s Washington bureau and worked in news gathering for USA Today and Al Jazeera English. Editor's note: This story has been updated with additional information. More on Product Recalls
Cancel You are leaving AARP.org and going to the website of our trusted provider. The provider’s terms, conditions and policies apply. Please return to AARP.org to learn more about other benefits. Your email address is now confirmed. You'll start receiving the latest news, benefits, events, and programs related to AARP's mission to empower people to choose how they live as they age. You can also by updating your account at anytime. You will be asked to register or log in. Cancel Offer Details Disclosures
Close In the next 24 hours, you will receive an email to confirm your subscription to receive emails related to AARP volunteering. Once you confirm that subscription, you will regularly receive communications related to AARP volunteering. In the meantime, please feel free to search for ways to make a difference in your community at Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.